|
MCM9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.632100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.938200E-03 |
| Normal-vs-Stage2 |
1.636770E-01 |
| Normal-vs-Stage3 |
4.694400E-02 |
| Normal-vs-Stage4 |
2.395500E-04 |
| Stage1-vs-Stage2 |
6.889600E-01 |
| Stage1-vs-Stage3 |
6.815800E-01 |
| Stage1-vs-Stage4 |
1.524350E-01 |
| Stage2-vs-Stage3 |
9.388000E-01 |
| Stage2-vs-Stage4 |
1.752360E-01 |
| Stage3-vs-Stage4 |
1.287800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.642300E-04 |
| Normal-vs-AfricanAmerican |
9.713700E-02 |
| Normal-vs-Asian |
3.118000E-01 |
| Caucasian-vs-AfricanAmerican |
6.959800E-01 |
| Caucasian-vs-Asian |
3.187500E-02 |
| AfricanAmerican-vs-Asian |
7.610500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81230000000565E-05 |
| Normal-vs-Female |
2.164600E-01 |
| Male-vs-Female |
3.561700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.271800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.585760E-02 |
| Normal-vs-Age(61-80Yrs) |
3.370100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.547800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.979800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.918400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.529000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.034200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.261000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.485800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.526400E-02 |
| Normal-vs-Grade 2 |
3.462500E-02 |
| Normal-vs-Grade 3 |
1.418100E-03 |
| Normal-vs-Grade 4 |
1.9358599999908E-05 |
| Grade 1-vs-Grade 2 |
6.107900E-02 |
| Grade 1-vs-Grade 3 |
1.087670E-02 |
| Grade 1-vs-Grade 4 |
9.045700E-04 |
| Grade 2-vs-Grade 3 |
2.869400E-01 |
| Grade 2-vs-Grade 4 |
9.004700E-03 |
| Grade 3-vs-Grade 4 |
3.784400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.793200E-01 |
| Normal-vs-ccB subtype |
7.68970000000202E-05 |
| ccA subtype-vs-ccB subtype |
5.416100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.592400E-02 |
| Normal-vs-N1 |
5.655700E-03 |
| N0-vs-N1 |
1.876360E-01 |
|
|
